Alvin Wong

5.6k total citations
72 papers, 2.0k citations indexed

About

Alvin Wong is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Alvin Wong has authored 72 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 23 papers in Oncology and 23 papers in Hematology. Recurrent topics in Alvin Wong's work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (17 papers) and Cancer Treatment and Pharmacology (9 papers). Alvin Wong is often cited by papers focused on Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (17 papers) and Cancer Treatment and Pharmacology (9 papers). Alvin Wong collaborates with scholars based in United States, Canada and Spain. Alvin Wong's co-authors include Lori Kunkel, David S. Siegel, Melissa Alsina, Robert Z. Orlowski, Rubén Niesvizky, Ashraf Badros, Ravi Vij, June K. Wu, Leanne McCulloch and Sundar Jagannath and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Alvin Wong

68 papers receiving 2.0k citations

Peers

Alvin Wong
Francis J. Giles United States
Ali Amirkhosravi United States
Michael Medinger Switzerland
Lei Gao China
Deborah L. Ornstein United States
Francis J. Giles United States
Alvin Wong
Citations per year, relative to Alvin Wong Alvin Wong (= 1×) peers Francis J. Giles

Countries citing papers authored by Alvin Wong

Since Specialization
Citations

This map shows the geographic impact of Alvin Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alvin Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alvin Wong more than expected).

Fields of papers citing papers by Alvin Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alvin Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alvin Wong. The network helps show where Alvin Wong may publish in the future.

Co-authorship network of co-authors of Alvin Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Alvin Wong. A scholar is included among the top collaborators of Alvin Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alvin Wong. Alvin Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bowen, Joanne M., Sofía Braga, John Finnie, et al.. (2024). Preclinical and clinical evaluation through serial colonoscopic evaluation of neratinib‐induced diarrhea in HER2‐positive breast cancer—A pilot study. Physiological Reports. 12(16). e70008–e70008. 4 indexed citations
2.
Wong, Alvin, et al.. (2022). Tissue Expander-Assisted Component Separation for Pediatric Abdominal Wall Reconstruction. Annals of Plastic Surgery. 88(4). S320–S324. 1 indexed citations
3.
Wong, Alvin, Samuel Lance, & Amanda A. Gosman. (2022). Treatment of Unicoronal Craniosynostosis by Rotational Flap Technique Preserves Blood Supply to the Frontal Bone Flap. Annals of Plastic Surgery. 88(4). S348–S350. 2 indexed citations
4.
Wong, Alvin, et al.. (2021). Rotation flap distraction osteogenesis for unicoronal synostosis. Neurosurgical Focus Video. 4(2). V16–V16. 1 indexed citations
5.
Barruet, Emilie, Steven Garcia, Lauren Byrnes, et al.. (2020). Functionally heterogeneous human satellite cells identified by single cell RNA sequencing. eLife. 9. 86 indexed citations
6.
Jiménez, M. Martín, Bent Ejlertsen, Janine Mansi, et al.. (2020). 83P Impact of treatment duration of extended adjuvant therapy with neratinib in early stage HER2+ HR+ breast cancer after trastuzumab-based therapy on patient outcomes. Annals of Oncology. 31. S43–S43. 2 indexed citations
7.
Wu, June K., Julie Monteagudo, John P. Andrews, et al.. (2015). Aberrant Lymphatic Endothelial Progenitors in Lymphatic Malformation Development. PLoS ONE. 10(2). e0117352–e0117352. 27 indexed citations
8.
9.
Wong, Alvin, et al.. (2013). Autoclaved Autologous Bone Graft for Orbital Reconstruction for Recurrent Temporal Bone Orbital Osteosarcoma. Journal of Craniofacial Surgery. 24(1). e59–e62. 2 indexed citations
10.
Alsina, Melissa, Suzanne Trudel, Richard R. Furman, et al.. (2012). A Phase I Single-Agent Study of Twice-Weekly Consecutive-Day Dosing of the Proteasome Inhibitor Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma or Lymphoma. Clinical Cancer Research. 18(17). 4830–4840. 119 indexed citations
11.
Wong, Alvin, et al.. (2012). Propranolol Accelerates Adipogenesis in Hemangioma Stem Cells and Causes Apoptosis of Hemangioma Endothelial Cells. Plastic & Reconstructive Surgery. 130(5). 1012–1021. 81 indexed citations
12.
Wang, Zhengping, Jinfu Yang, Christopher J. Kirk, et al.. (2012). Clinical Pharmacokinetics, Metabolism, and Drug-Drug Interaction of Carfilzomib. Drug Metabolism and Disposition. 41(1). 230–237. 123 indexed citations
13.
Chang, Catherine S., Alvin Wong, Christine H. Rohde, Jeffrey A. Ascherman, & June K. Wu. (2011). Management of lip hemangiomas: Minimizing peri-oral scars. Journal of Plastic Reconstructive & Aesthetic Surgery. 65(2). 163–168. 15 indexed citations
14.
Wong, Alvin, Karen A. Tong, Elisa Boscolo, et al.. (2011). Expression of HES and HEY genes in infantile hemangiomas. PubMed. 3(1). 19–19. 22 indexed citations
15.
Rosen, Peter J., E. A. Sausville, Kyriakos P. Papadopoulos, et al.. (2009). Phase II results of Study PX-171–007: A phase Ib/II study of carfilzomib (CFZ), a selective proteasome inhibitor, in patients with selected advanced metastatic solid tumors. Journal of Clinical Oncology. 27(15_suppl). 3515–3515. 5 indexed citations
16.
Albertella, Mark R., Paul M. Loadman, Philip H. Jones, et al.. (2008). Hypoxia-Selective Targeting by the Bioreductive Prodrug AQ4N in Patients with Solid Tumors: Results of a Phase I Study. Clinical Cancer Research. 14(4). 1096–1104. 98 indexed citations
17.
Beer, Tomasz M., Milind Javle, Christopher W. Ryan, et al.. (2006). Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer. Cancer Chemotherapy and Pharmacology. 59(5). 581–587. 41 indexed citations
18.
Cleland, Jeffrey L., Alvin Wong, & Susan E. Alters. (2005). The targeted cytotoxic prodrug, AQ4N, persists in the spleen, large intestine, and subcutaneous tumors. Cancer Research. 65. 565–565.
19.
Chiong, Edmund, et al.. (2005). Review of Clinical Manifestations of Biochemically-advanced Prostate Cancer Cases. Asian Journal of Surgery. 28(3). 202–206. 6 indexed citations
20.
Wong, Alvin, Leanne McCulloch, & Augusto Sola. (1992). Treatment of peripheral tissue ischemia with topical nitroglycerin ointment in neonates. The Journal of Pediatrics. 121(6). 980–983. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026